Imperative Care Raises $260 Million to Advance Innovations that Elevate Stroke Care

18 Jul, 2021

Imperative Care Raises $260 Million to Advance Innovations that Elevate Stroke Care
Photo by Amith Nair on Unsplash

– Imperative Care, Inc. announced that it has closed a $260m Series D financing led by D1 Capital Partners.
– New investors HealthCor Investments LLC and Innovatus Capital Partners also joined the round. Existing Imperative Care investors Ally Bridge Group, Bain Capital Life Sciences, Ascension Ventures, Delos Capital, Rock Springs Capital, and Amed Ventures participated in the financing.
– James Rogers from D1 will join Imperative Care’s Board of Directors.
– Proceeds from the financing will be used to support ongoing commercialization and development of a wide range of Imperative Care’s technologies in the broad continuum of stroke care, as well as to create a strategic network of wholly owned development subsidiaries in a number of areas of synergy.

Health Care Medical Medical Device North America
Crunchbase icon

Content report

The following text will be sent to our editors: